Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
N. Plevris (Lead / Corresponding author), C. S. Chuah, R. M. Allen, I. D. Arnott, P. N. Brennan, S. Chaudhary, A. M. D. Churchhouse, S. Din, E. Donoghue, Daniel R. Gaya, M. Groome, H. M. Jafferbhoy, P. W. Jenkinson, W. L. Lam, M. Lyons, J. C. Macdonald, M. MacMaster, C. Mowat, G. D. Naismith, L. F. PottsE. Saffouri, J. P. Seenan, A. Sengupta, P. Shasi, D. I. Sutherland, J. A. Todd, J. Veryan, A. J. M. Watson, David Watts, G. R. Jones, C. W. Lees
Dive into the research topics of 'Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort'. Together they form a unique fingerprint.